IMMP Stock Analysis: Buy, Sell, or Hold?
IMMP - Immutep Limited American Depositary Shares
$0.40
0.02 (5.32%)
â˛
5d:
+7.57%
30d:
-7.6%
90d:
-13.02%
WAIT
LOW Confidence
Analysis Updated: Aug 13, 2026 12:00 AM ET
Earnings: Sep 04, 2026
20d
Get Alerted When IMMP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: IMMP is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: IMMP is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: IMMP is currently trading at $0.40, which is considered fair relative to its 30-day fair value range of $0.38 to $0.43.
Technical Outlook: Technically, IMMP is showing sideways momentum. The price is approaching resistance at $0.41. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.3% recently.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $1.50 (+271.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IMMP is showing sideways momentum. The price is approaching resistance at $0.41. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.3% recently.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $1.50 (+271.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.38 -
$0.43
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (44/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.3%)
- BULLISH: Trading 271.7% below Wall St target ($1.50)
- WARNING: Composite score 45/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.38 -
$0.43
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.36
Resistance Level
$0.41
Current Trend
Sideways
Technical data as of
Aug 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.02
Wall Street Target
$1.50
(+271.7%)
Revenue Growth (YoY)
91.5%
Share & Embed Analysis
Last updated: August 14, 2026 4:56 AM ET
Data refreshes hourly during market hours. Next update: 5:56 AM
Data refreshes hourly during market hours. Next update: 5:56 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMMP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical âĻ |
STRONG BUY
29 analysts |
$88 | 35 SELL |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$282 | 63 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 51 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$106 | 49 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$125 | 47 HOLD |
